Section of Addiction Medicine

The OHSU Addiction Medicine Section houses a multidisciplinary group of outstanding physicians. Our addiction medicine team is dedicated to serving the people of Oregon. The team provides excellent clinical care for people living with substance use disorders. They also serve the region and the nation through research and education.

Clinical care

Addiction Medicine faculty provide direct services for people living with substance use disorder. Our clinics offer office-based buprenorphine and other medications for treatment of substance use disorders.

Interdisciplinary care at the OHSU hospital

OHSU’s interdisciplinary inpatient addiction medicine consult service (IMPACT) offers initiation of treatment for substance use disorders during hospitalization. People admitted to OHSU for medical and surgical conditions can receive this care. Dr. Honora Englander directs this service.

Learn more about our IMPACT service here on our new website!

Getting community care after discharge

The program facilitates linkage to community care upon discharge. Services include medically supervised withdrawal, intensive outpatient, and residential treatment. Community-based faculty are at:

Central City Concern - visit site

CODA - visit site

Recovery Works NW - visit site

Allied Health Services of Portland - visit site

Portland VA - visit site

Kaiser Permanente - visit site

Section news

New Contingency Management Project at OHSU

Treatment for Opioid Use Disorder is Not Easy to Access

Dr. Honora Englander recently published in NEJM

Hospital Standards of Care for People with Substance Use Disorder

Please read here:

OHSU's roundtable on fentanyl

Please watch the recording of our section's roundtable regarding the deadly effects of synthetic fentanyl.

DGIM's HRBR clinic

Read more on our main Internal Medicine page:


Addiction medicine faculty advance addiction and pain management education for learners at all training levels, both locally and nationally.

The OHSU Addiction Medicine Fellowship provides intensive training for physicians. Physicians can become experts in treating substance use disorders across all parts of the healthcare spectrum.

The Oregon Addiction Prevention and Education Initiative provides buprenorphine-waiver training to physicians across Oregon. It also provides other addiction-related education.

The addiction medicine program hosts tele-mentoring (ECHO) CME programs under the direction of Dr. Daniel Hoover.

Oregon ECHO network – learn more

Addiction medicine fellowship – learn more

The NIH HCV Elimination Webinar, reporting prelim results of Oregon HOPE peer engagement and TeleHCV treatment studies (Korthuis)
American Liver Foundation/CDC webinar on Central City/Oregon HOPE hepatitis C elimination programs (Seaman)
National Viral Hepatitis Roundtable webinar (Seaman)


An OHSU study was recently cited in the New York Times.

A link to the NYT article is here
A direct link to the study  is here

Read about OHSU's recently published BRAVO study.

New study examines addiction medicine treatment in Vietnam | OHSU News

OHSU hosts the Western States Node of National Institute on Drug Abuse’s Clinical Trials Network (CTN). This program tests emerging treatments for opioid, methamphetamines and cocaine use disorders.

Western States Node of NIDA Clinical Trials Network – visit site

Faculty collaborate with the Methamphetamines Addiction Research Center (MARC) and Advanced Imaging Research Center (AIRC) at OHSU to conduct methamphetamines research.

Methamphetamines Addiction Research Center – learn more

Advanced Imaging Research Center – learn more

Other NIH-funded health services and clinical trials research focuses on improving treatment of opioid use disorder in rural Oregon, nationally and internationally.